These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35677737)
21. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Roderick P; Ferris G; Wilson K; Halls H; Jackson D; Collins R; Baigent C Health Technol Assess; 2005 Dec; 9(49):iii-iv, ix-x, 1-78. PubMed ID: 16336844 [TBL] [Abstract][Full Text] [Related]
22. Update in the treatment of venous thromboembolism. Garcia DA; Spyropoulos AC Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085 [TBL] [Abstract][Full Text] [Related]
23. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin. Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321 [TBL] [Abstract][Full Text] [Related]
24. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. van Der Heijden JF ; Hutten BA; Büller HR; Prins MH Cochrane Database Syst Rev; 2000; (4):CD002001. PubMed ID: 11034739 [TBL] [Abstract][Full Text] [Related]
25. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Schaefer JK; McBane RD; Black DF; Williams LN; Moder KG; Wysokinski WE Thromb Haemost; 2014 Nov; 112(5):947-50. PubMed ID: 25118790 [TBL] [Abstract][Full Text] [Related]
26. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272 [TBL] [Abstract][Full Text] [Related]
27. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188 [TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711 [TBL] [Abstract][Full Text] [Related]
29. A case of antiphospholipid syndrome refractory to secondary anticoagulating prophylaxis after deep vein thrombosis-pulmonary embolism. Gu KM; Shin JW; Park IW Tuberc Respir Dis (Seoul); 2014 Dec; 77(6):274-8. PubMed ID: 25580146 [TBL] [Abstract][Full Text] [Related]
30. A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome. Vaidya B; Nakarmi S; Joshi R; Baral R JNMA J Nepal Med Assoc; 2019; 57(216):133-145. PubMed ID: 31477950 [TBL] [Abstract][Full Text] [Related]
31. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
32. Warfarin Failure in a Patient With Chronic Thromboembolic Pulmonary Hypertension: A Case Report and Literature Review. Dolkar T; Chaudry A; Salauddin F; Nway N; Kadakia N; Kalavar M; Dogar MH Cureus; 2022 Jul; 14(7):e27007. PubMed ID: 35989750 [TBL] [Abstract][Full Text] [Related]
33. The management of thrombosis in the antiphospholipid-antibody syndrome. Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428 [TBL] [Abstract][Full Text] [Related]
34. [Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]. Wernicke S; Selleng K; Felix SB; Greinacher A; Hammer F Internist (Berl); 2017 Jul; 58(7):735-739. PubMed ID: 28265683 [TBL] [Abstract][Full Text] [Related]
35. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis. Brunner HI; Chan WS; Ginsberg JS; Feldman BM J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562 [TBL] [Abstract][Full Text] [Related]
36. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Ruiz-Irastorza G; Hunt BJ; Khamashta MA Arthritis Rheum; 2007 Dec; 57(8):1487-95. PubMed ID: 18050167 [TBL] [Abstract][Full Text] [Related]
37. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis. Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527 [TBL] [Abstract][Full Text] [Related]
38. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months. Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181 [TBL] [Abstract][Full Text] [Related]
39. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis. Kearon C; Harrison L; Crowther M; Ginsberg JS Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648 [TBL] [Abstract][Full Text] [Related]
40. Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case Report. Fong B; Novak D; Dalley M; Alfred G J Emerg Med; 2018 Apr; 54(4):533-536. PubMed ID: 29449120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]